HLS
HEALIUS ORDINARYHealius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
HLS
HLS
HEALIUS ORDINARY
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 10.36% | — |
| 10 July | 10.29% | — |
| 9 July | 10.20% | — |
| 8 July | 10.14% | — |
| 7 July | 10.02% | — |
| 6 July | 9.96% | — |
| 3 July | 9.98% | — |
| 2 July | 9.98% | — |
| 1 July | 10.03% | — |
Healius (HLS) Short Interest Summary
Healius (HLS) currently has 10.36% of its shares sold short (75.2 million shares, worth approximately $30.1 million), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes HLS the #13 most shorted stock on the ASX most shorted list. Short interest in HLS is up 0.40% over the past week and up 0.61% over the past month. HLS is part of the Health Care sector on the ASX.
Recent HLS Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 10.36% | 75.2M | $0.38 |
| 10 July 2026 | 10.29% | 74.7M | $0.38 |
| 9 July 2026 | 10.20% | 74.1M | $0.39 |
| 8 July 2026 | 10.14% | 73.6M | $0.38 |
| 7 July 2026 | 10.02% | 72.8M | $0.38 |
| 6 July 2026 | 9.96% | 72.3M | $0.38 |
| 3 July 2026 | 9.98% | 72.5M | $0.38 |
| 2 July 2026 | 9.98% | 72.5M | $0.38 |
| 1 July 2026 | 10.03% | 72.8M | $0.37 |
| 30 June 2026 | 10.54% | 76.6M | $0.39 |
HLS Short Selling — Frequently Asked Questions
What is Healius (HLS)'s current short interest?
Healius (HLS) currently has a short interest of 10.36% of total shares outstanding. This means 10.36% of HLS's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is HLS heavily shorted on the ASX?
Yes. With 10.36% of its shares sold short, HLS is considered heavily shorted — short interest above 10% is generally regarded as high. HLS is currently ranked #13 among the most shorted stocks on the ASX.
What does short interest mean for HLS investors?
Short interest in HLS shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 10.36%, HLS's high short interest could signal strong bearish sentiment — or potential for a short squeeze if the price rises. See our short squeeze candidates and days to cover analysis for more context.
Where does this HLS short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for HLS.